 | Up a level |
Denegri, A; Räber, Lorenz; Windecker, Stephan; Gencer, B; Mach, F; Rodondi, Nicolas; Heg, D; Nanchen, D; Matter, C; Luescher, T F (2020). Best Poster Award - Third Prize: The Perilousness of Antidepressant Drugs in a Real-world Cohort of Patients with Acute Coronary Syndrome. European cardiology, 15, e26. Touch Briefings 10.15420/ecr.2020.15.1.PO3
Gencer, B; Rodondi, Nicolas; Mach, F (2014). PCSK9 inhibitors: emerging treatment to lower cholesterol? Revue médicale suisse, 10(420), pp. 539-542. Médecine & Hygiène
Matter, C; Klingenberg, R; Templin, C; Altwegg, L; Räber, L; Carballo, D; Auer, R; Landmesser, U; Maier, W; Windecker, S; Jüni, P; Mach, F; Keller, PF; Rodondi, N; Lüscher, TF (2010). Inflammation and acute coronary syndromes (ACS) a clinical research network funded by the Swiss National Science Foundation. Cardiovascular medicine, 13, pp. 31-34. Muttenz: EMH Swiss Medical Publishers Ltd
Gencer, B; Carballo, D; Nanchen, D; Koskinas, K; Klingenberg, R; Raeber, L; Auer, R; Carballo, S; Heg, D; Windecker, S; Luscher, T F; Matter, C M; Rodondi, N; Mach, F (21 October 2019). P1222Intensification of lipid lowering therapy before and after publication of the IMPROVE-IT trial: A temporal analysis from the SPUM-ACS cohort. European Heart Journal, 40(Supplement_1), p. 678. 10.1093/eurheartj/ehz748.0180
Denegri, A; Magnani, G; Rossi, V A; Raeber, L; Windecker, S; Gencer, B; Mach, F; Rodondi, N; Heg, D; Nanchen, D; Matter, C M; Luescher, T F (October 2019). P6440The perils of polyvascular disease with concomitant type 2 diabetes in a real-world cohort of patients with acute coronary syndrome. European Heart Journal, 40(Supplement_1), p. 4040. 10.1093/eurheartj/ehz746.1034
